There is a version of this review that starts with the ingredients, and it would be dishonest. The category this cream belongs to — brightening for underarms, inner thighs, the bikini line, 'sensitive areas' — exists largely because a great many people, and disproportionately people with medium and deep skin tones, have been taught to see the natural darkness of skin in folds as a flaw. It is not one. Skin that rubs against skin, sits under arms and behind knees, and carries more melanocytes per square inch than the forearm is darker in nearly everyone, and it is meant to be. No cream changes that baseline, and any product that implies it can is selling something other than skincare. So before anything else: if the darkness you are looking at is simply the tone of your fold skin, put the $47 back in your pocket. This review is for the narrower and real problem of darkening that was not there before — the marks shaving, waxing and chafing leave behind — and for the question of whether a serious dermatological laboratory can make something defensible inside a dubious category.
Bioderma, to its credit, mostly has. Pigmentbio launched in 2019 as the company's pharmacy answer to the hydroquinone era, built on a patented pairing of lysine azelate — azelaic acid formed into a salt with the amino acid lysine, chosen for gentleness and solubility — and glabridin, the tyrosinase-inhibiting flavonoid from licorice root. Both are here, the azelate at position twenty-one with its lysine two places above, the licorice extract near the end. Alongside them sits a small dose of salicylic acid, which does the underrated job in these areas: thinning the keratin-thickened surface that friction builds up and that makes folds look darker than their pigment alone would. Andrographis leaf extract, an Ayurvedic bitter, is credited by Bioderma with acting on melanogenesis and is more safely described as an anti-inflammatory helper. There is no hydroquinone, no mercury, no corticosteroid — the three ingredients that make unregulated lightening creams both effective and dangerous — and no fragrance, which matters enormously on skin this thin and this often irritated.
The base deserves as much attention as the actives, because where this cream goes is the whole point. Dimethicone and polymethylsilsesquioxane sit fourth and fifth, giving a light lotion that dries in under a minute to a soft, faintly powdery finish with no tack and nothing left on a bra strap or a waistband. That finish also reduces skin-on-skin friction, which is half the mechanism of friction darkening in the first place; a cream that simply made the inner thighs slide past each other more easily would help, and this one does that as well as everything else.
Used daily on underarms that have been shaved for years, the pattern over two months is modest and believable. The first thing to change is comfort: the post-shave rash settles within a week, which is the glabridin's anti-inflammatory side and the silicone slip. The tone shifts more slowly and more subtly — the reddish-brown halo of shaving irritation softens by week four or five, and by week eight the area looks more even, though not lighter than the skin around it, because it was never going to be. Bioderma's own use test, sixty-two women, reports a 45% reduction in the appearance of marks at one month and 89% satisfaction, and those numbers are consistent with what the cream does when the darkening is genuinely post-inflammatory and the shaving continues in a gentler way. Freshly shaved or waxed skin is the exception: the acids sting on open follicles, and the cream should wait a day.
Two things it cannot do need saying plainly. The doses are cautious — azelaic acid at position twenty-one is a fraction of the 15–20% in prescription products, and glabridin is a supporting act — so results on established, long-standing marks are slow and partial, and the price buys maintenance rather than transformation. And a dark, velvety, thickened patch in the neck, underarms or groin may be acanthosis nigricans, a skin sign of insulin resistance that no topical brightener touches; it looks like exactly the thing this category advertises against, and it needs a doctor, not a tube. A product sold for 'sensitive areas' should say that on the box. It does not, and this review will.
The price is the other honest reservation. Forty-seven dollars for 75 ml puts this among the dearer body treatments in a pharmacy, and what it buys is a well-made, well-tolerated cream with maintenance-strength actives and a patent behind it. A tube covers two months of twice-daily use on underarms and bikini line. Retailer reviews run in the low-to-mid fours and say what the formula predicts: comfortable, non-sticky, calms shaving irritation, slow and modest on tone, expensive. Nobody in them reports the dramatic before-and-after the category's marketing traffics in, which is to Bioderma's credit and the category's shame.
So: for the person with real post-shave or friction darkening who wants a gentle, fragrance-free, non-bleaching cream from a laboratory rather than an influencer, this is the most defensible product of its kind and it does what its restrained claims say, slowly. For the person who was told their underarms or thighs should match their forearm, the best advice is that they should not, and that the only thing wrong is the advice.
